1 patient evaluation
for
Obinutuzumab
with a side effects
rating of Moderate

Aug 26, 2017
(Started Feb 28, 2017)

Effectiveness

Can't tell
(for follicular lymphoma)

Side effects

Moderate
(nausea)

Adherence

Usually

Burden

Somewhat hard to take

Dosage:
25 mg
Every 3 months

Advice & Tips:
Currently on hold with this treatment. Side effects of Bendeka/Gazyva have been so severe I had to srop both. I have had one treatment with Gazyva alone with inconclusive results. If and when I recover from the Bendeka side effects, I will likely try Gazyva again.